rs773316961
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4BP6BS1BS2
The NM_002047.4(GARS1):c.1817G>A(p.Ser606Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000105 in 1,612,580 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_002047.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GARS1 | ENST00000389266.8 | c.1817G>A | p.Ser606Asn | missense_variant | Exon 15 of 17 | 1 | NM_002047.4 | ENSP00000373918.3 | ||
GARS1 | ENST00000675651.1 | c.1817G>A | p.Ser606Asn | missense_variant | Exon 15 of 17 | ENSP00000502513.1 | ||||
GARS1 | ENST00000675810.1 | c.1715G>A | p.Ser572Asn | missense_variant | Exon 14 of 16 | ENSP00000502743.1 | ||||
GARS1 | ENST00000675693.1 | c.1649G>A | p.Ser550Asn | missense_variant | Exon 16 of 18 | ENSP00000502174.1 | ||||
GARS1 | ENST00000675051.1 | c.1616G>A | p.Ser539Asn | missense_variant | Exon 15 of 17 | ENSP00000502296.1 | ||||
GARS1 | ENST00000674815.1 | c.1448G>A | p.Ser483Asn | missense_variant | Exon 15 of 17 | ENSP00000502799.1 | ||||
GARS1 | ENST00000674851.1 | c.1448G>A | p.Ser483Asn | missense_variant | Exon 16 of 18 | ENSP00000502451.1 | ||||
GARS1 | ENST00000444666.6 | n.*238G>A | non_coding_transcript_exon_variant | Exon 16 of 18 | 3 | ENSP00000415447.2 | ||||
GARS1 | ENST00000674616.1 | n.*1531G>A | non_coding_transcript_exon_variant | Exon 16 of 18 | ENSP00000502408.1 | |||||
GARS1 | ENST00000674643.1 | n.*917G>A | non_coding_transcript_exon_variant | Exon 16 of 17 | ENSP00000501636.1 | |||||
GARS1 | ENST00000674737.1 | n.*1155G>A | non_coding_transcript_exon_variant | Exon 16 of 18 | ENSP00000502464.1 | |||||
GARS1 | ENST00000674807.1 | n.*90G>A | non_coding_transcript_exon_variant | Exon 14 of 16 | ENSP00000502814.1 | |||||
GARS1 | ENST00000675529.1 | n.*1687G>A | non_coding_transcript_exon_variant | Exon 16 of 18 | ENSP00000501655.1 | |||||
GARS1 | ENST00000676088.1 | n.*1759G>A | non_coding_transcript_exon_variant | Exon 17 of 19 | ENSP00000501884.1 | |||||
GARS1 | ENST00000676140.1 | n.*762G>A | non_coding_transcript_exon_variant | Exon 15 of 17 | ENSP00000502571.1 | |||||
GARS1 | ENST00000676164.1 | n.*1268G>A | non_coding_transcript_exon_variant | Exon 15 of 17 | ENSP00000501986.1 | |||||
GARS1 | ENST00000676210.1 | n.*1106G>A | non_coding_transcript_exon_variant | Exon 16 of 18 | ENSP00000502373.1 | |||||
GARS1 | ENST00000676259.1 | n.*1249G>A | non_coding_transcript_exon_variant | Exon 15 of 17 | ENSP00000501980.1 | |||||
GARS1 | ENST00000444666.6 | n.*238G>A | 3_prime_UTR_variant | Exon 16 of 18 | 3 | ENSP00000415447.2 | ||||
GARS1 | ENST00000674616.1 | n.*1531G>A | 3_prime_UTR_variant | Exon 16 of 18 | ENSP00000502408.1 | |||||
GARS1 | ENST00000674643.1 | n.*917G>A | 3_prime_UTR_variant | Exon 16 of 17 | ENSP00000501636.1 | |||||
GARS1 | ENST00000674737.1 | n.*1155G>A | 3_prime_UTR_variant | Exon 16 of 18 | ENSP00000502464.1 | |||||
GARS1 | ENST00000674807.1 | n.*90G>A | 3_prime_UTR_variant | Exon 14 of 16 | ENSP00000502814.1 | |||||
GARS1 | ENST00000675529.1 | n.*1687G>A | 3_prime_UTR_variant | Exon 16 of 18 | ENSP00000501655.1 | |||||
GARS1 | ENST00000676088.1 | n.*1759G>A | 3_prime_UTR_variant | Exon 17 of 19 | ENSP00000501884.1 | |||||
GARS1 | ENST00000676140.1 | n.*762G>A | 3_prime_UTR_variant | Exon 15 of 17 | ENSP00000502571.1 | |||||
GARS1 | ENST00000676164.1 | n.*1268G>A | 3_prime_UTR_variant | Exon 15 of 17 | ENSP00000501986.1 | |||||
GARS1 | ENST00000676210.1 | n.*1106G>A | 3_prime_UTR_variant | Exon 16 of 18 | ENSP00000502373.1 | |||||
GARS1 | ENST00000676259.1 | n.*1249G>A | 3_prime_UTR_variant | Exon 15 of 17 | ENSP00000501980.1 | |||||
GARS1 | ENST00000675859.1 | n.*83-792G>A | intron_variant | Intron 13 of 14 | ENSP00000502033.1 | |||||
GARS1 | ENST00000676403.1 | n.1810-792G>A | intron_variant | Intron 14 of 15 | ENSP00000502681.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152084Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000281 AC: 7AN: 248980Hom.: 0 AF XY: 0.0000444 AC XY: 6AN XY: 135184
GnomAD4 exome AF: 0.00000959 AC: 14AN: 1460496Hom.: 0 Cov.: 29 AF XY: 0.0000110 AC XY: 8AN XY: 726650
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152084Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74248
ClinVar
Submissions by phenotype
Charcot-Marie-Tooth disease type 2 Uncertain:1
This sequence change replaces serine, which is neutral and polar, with asparagine, which is neutral and polar, at codon 606 of the GARS protein (p.Ser606Asn). This variant is present in population databases (rs773316961, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with GARS-related conditions. ClinVar contains an entry for this variant (Variation ID: 543238). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt GARS protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not provided Benign:1
GARS1: BS2 -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at